Vaccination Status, Knowledge and Attitude in Korean Patients With IBD

December 24, 2022 updated by: Byong Duk Ye, Asan Medical Center

Vaccination Status, Knowledge About Vaccination and Attitude to Vaccination in Korean Patients With Inflammatory Bowel Diseases

The purpose of this study is to investigate the vaccination status, knowledge about vaccination, and attitude to vaccination of the Korean patients with inflammatory bowel diseases

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Using structured questionnaires, the vaccination status, knowledge about vaccination, and attitude to vaccination of the Korean patients with inflammatory bowel diseases will be investigated. The descriptive analyses will be performed and the factors influencing the vaccination status, knowledge, and attitude will be investigated.

Study Type

Observational

Enrollment (Actual)

287

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients with inflammatory bowel diseases who are visiting Asan Medical Center and who give consent to the survey

Description

Inclusion Criteria:

  • Crohn's disease or ulcerative colitis
  • Patients who are visiting Asan Medical Center for the first time for the management of inflammatory bowel diseases
  • Patients who give consent for participating in the study

Exclusion Criteria:

  • Patients who refuse to participate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Inflammatory bowel diseases
Patients who have inflammatory bowel diseases and who give consent to participate in the survey
Other: Survey with structured questionnaire form for inflammatory bowel disease patient group
For patients with inflammatory bowel disease, survey with structured questionnaire form is carried out.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Vaccination status (MMR, DTaP, BCG, Polio, seasonal influenza, pneumococcus, HAV, HBV, HPV, VZV, and menigococcus )
Time Frame: One year
Vaccination status (MMR, DTaP, BCG, Polio, seasonal influenza, pneumococcus, HAV, HBV, HPV, VZV, and menigococcus )
One year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knowledge about vaccination in patients with inflammatory bowel diseases
Time Frame: One year
Knowledge about vaccination in patients with inflammatory bowel diseases
One year

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Attitude to vaccination in patients with inflammatory bowel diseases
Time Frame: One year
Attitude to vaccination in patients with inflammatory bowel diseases
One year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Asan Medical Center

Investigators

  • Principal Investigator: Byong Duk Ye, MD, PhD, Asan Medical Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2013

Primary Completion (Actual)

December 1, 2015

Study Completion (Actual)

March 1, 2016

Study Registration Dates

First Submitted

November 4, 2013

First Submitted That Met QC Criteria

November 8, 2013

First Posted (Estimate)

November 15, 2013

Study Record Updates

Last Update Posted (Estimate)

December 28, 2022

Last Update Submitted That Met QC Criteria

December 24, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2013-0592

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Inflammatory Bowel Disease

Clinical Trials on Survey with structured questionnaire form for inflammatory bowel disease patient group

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe